Sanofi-Aventis hands back flu vaccine programme to Crucell
This article was originally published in Scrip
Executive Summary
Crucell has reacquired the rights to a cell-based influenza vaccine programme from Sanofi-Aventis's vaccine subsidiary Sanofi Pasteur.